Table 8.
Post-PSM Evaluation of therapeutic efficacy of patients after treatment
| Tumor response | Control group (n = 41) | Research group (n = 41) | t/χ2 | P |
|---|---|---|---|---|
| CR | 2 (4.88) | 4 (9.76) | 5.658 | 0.130 |
| PR | 8 (19.51) | 15 (36.59) | ||
| PD | 19 (46.34) | 9 (21.95) | ||
| SD | 12 (29.27) | 13 (31.71) | ||
| ORR | 24.39% | 46.34% | 4.321 | 0.038 |
| DCR | 53.66% | 78.05% | 5.423 | 0.020 |
Note: CR, Complete Response; PR, Partial Response; PD, Progressive Disease; SD, Stable Disease; ORR, Overall Response Rate; DCR, Disease Control Rate; PSM, Propensity Score Matching.